Technology
Health
Biotechnology
Correvio Pharma
$2.309876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.12 (-4.96%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell CORV and other stocks, options, ETFs, and crypto commission-free!
About
Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. Read More The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients, and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada.
Employees
138
Headquarters
Vancouver, British Columbia
Founded
1986
Market Cap
91.66M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
185.68K
High Today
$2.46
Low Today
$2.29
Open Price
$2.43
Volume
53.35K
52 Week High
$5.24
52 Week Low
$2.00
Collections
Technology
Health
Biotechnology
Pharmaceutical
Medical
Healthcare
Canada
North America
News
Yahoo FinanceMay 1
Correvio to Report First Quarter 2019 Financial Results on May 8, 2019
Conference Call Scheduled for Wednesday, May 8, 2019 at 8:30 a.m. Eastern (5:30 a.m. Pacific) NASDAQ: CORV TSX: CORV VANCOUVER , May 1, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, announces that it will report financial results for the first quarter ended March 31, 2019 on Wednesday, May 8, 2019 . Correvio will hold a conference call and webcast at 8:30 a.m. Eastern (5:30 a.m. Pacific) on that day to discuss ...
Price Paid on Robinhood
30% Lower
Right Now
52 Week Low
$2.00
Average Price Paid
$3.26
52 Week High
$5.24
Earnings
-$0.37
-$0.27
-$0.17
-$0.07
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 7, Pre-Market